Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD95' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1053 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Steinbach, JP; Supra, P; Huang, HJS; Cavenee, WK; Weller, M
      CD95-mediated apoptosis of human glioma cells: Modulation by epidermal growth factor receptor activity

      BRAIN PATHOLOGY
    2. Rivas, C; Miller, ARM; Collado, M; Lam, EWF; Apperley, JF; Melo, JV
      BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

      MOLECULAR THERAPY
    3. Treon, SP; Mitsiades, C; Mitsiades, N; Young, G; Doss, D; Schlossman, R; Anderson, KC
      Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies

      JOURNAL OF IMMUNOTHERAPY
    4. Sartorius, U; Schmitz, I; Krammer, PH
      Molecular mechanisms of death-receptor-mediated apoptosis

      CHEMBIOCHEM
    5. Sen, CK; Roy, S
      Redox control of caspases

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    6. Bidere, N; Senik, A
      Caspase-independent apoptotic pathways in T lymphocytes: A minireview

      APOPTOSIS
    7. Martin-Villalba, A; Hahne, M; Kleber, S; Vogel, J; Falk, W; Schenkel, J; Krammer, PH
      Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke

      CELL DEATH AND DIFFERENTIATION
    8. Wagenknecht, B; Roth, W; Gulbins, E; Wolburg, H; Weller, M
      C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis

      CELL DEATH AND DIFFERENTIATION
    9. Strater, J; Walczak, H; Hasel, C; Melzner, I; Leithauser, F; Moller, P
      CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies

      CELL DEATH AND DIFFERENTIATION
    10. Fumarola, C; Zerbini, A; Guidotti, GG
      Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis

      CELL DEATH AND DIFFERENTIATION
    11. Bernhard, D; Skvortsov, S; Tinhofer, I; Hubl, H; Greil, R; Csordas, A; Kofler, R
      Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts

      CELL DEATH AND DIFFERENTIATION
    12. Restifo, NP
      Countering the 'counterattack' hypothesis

      NATURE MEDICINE
    13. Ni, X; Hazarika, P; Zhang, CL; Tapur, R; Duvic, M
      Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+cytotoxic T lymphocytes in mycosis fungoides: A potential mechanism of tumor immune escape?

      CLINICAL CANCER RESEARCH
    14. Owen-Schaub, L
      Soluble Fas and cancer

      CLINICAL CANCER RESEARCH
    15. Ugurel, S; Rappl, G; Tilgen, W; Reinhold, U
      Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients

      CLINICAL CANCER RESEARCH
    16. Ding, HF; Fisher, DE
      P53, caspase 8, and regulation of apoptosis after ionizing radiation

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    17. Gan, YH; Lui, SSN; Malkovsky, M
      Differential susceptibility of naive and activated human gamma delta T cells to activation-induced cell death by T-cell receptor cross-linking

      MOLECULAR MEDICINE
    18. Schrantz, N; Bourgeade, MF; Mouhamad, S; Leca, G; Sharma, S; Vazquez, A
      p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGF beta-induced apoptosis in human Burkitt lymphoma B cells BL41

      MOLECULAR BIOLOGY OF THE CELL
    19. Yeh, YA; Wang, JW; Fan, CY; MacLeod, SL; Fan, K
      Expression of Fas ligand in metastatic prostatic carcinoma: Suggestive of possible clonal expansion of subpopulation with metastatic potential

      DIAGNOSTIC MOLECULAR PATHOLOGY
    20. Gerhardt, E; Kugler, S; Leist, M; Beier, C; Berliocchi, L; Volbracht, C; Weller, M; Bahr, M; Nicotera, P; Schulz, JB
      Cascade of caspase activation in potassium-deprived cerebellar granule neurons: Targets for treatment with peptide and protein inhibitors of apoptosis

      MOLECULAR AND CELLULAR NEUROSCIENCE
    21. Okada, Y; Kato, M; Minakami, H; Inoue, Y; Morikawa, A; Otsuki, K; Kimura, H
      Reduced expression of flice-inhibitory protein (FLIP) and NF kappa B is associated with death receptor-induced cell death in human aortic endothelialcells (HAECs)

      CYTOKINE
    22. Jackel, MC; Mitteldorf, C; Schweyer, S; Fuzesi, L
      Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    23. Landowski, TH; Moscinski, L; Burke, R; Buyuksal, I; Painter, JS; Goldstein, S; Dalton, WS
      CD95 antigen mutations in hematopoietic malignancies

      LEUKEMIA & LYMPHOMA
    24. Ten Bosch, JV; Otten, J; Thielemans, K
      Autoimmune Lymphoproliferative Syndrome type III, an indefinite disorder

      LEUKEMIA & LYMPHOMA
    25. ten Bosch, JV; Otten, J; Thielemans, K
      Autoimmune lymphoproliferative syndrome type III: An indefinite disorder

      LEUKEMIA & LYMPHOMA
    26. Pervaiz, S
      Resveratrol - from the bottle to the bedside?

      LEUKEMIA & LYMPHOMA
    27. Marie, JP
      Drug resistance in hematologic malignancies

      CURRENT OPINION IN ONCOLOGY
    28. Matute-Bello, G; Liles, WC; Frevert, CW; Nakamura, M; Ballman, K; Vathanaprida, C; Kiener, PA; Martin, TR
      Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    29. Hsu, PN; Lin, HH; Tu, CF; Chen, NJ; Wu, KM; Tsai, HF; Hsieh, SL
      Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts

      JOURNAL OF BIOMEDICAL SCIENCE
    30. Ichikura, T; Majima, T; Uchida, T; Okura, E; Ogawa, T; Mochizuki, H
      Plasma soluble Fas ligand concentration: Decrease in elderly men and increase in patients with gastric carcinoma

      ONCOLOGY REPORTS
    31. Komata, T; Koga, S; Hirohata, S; Takakura, M; Germano, IM; Inoue, M; Kyo, S; Kondo, S; Kondo, Y
      A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptasegene promoter

      INTERNATIONAL JOURNAL OF ONCOLOGY
    32. Elnemr, A; Ohta, T; Yachie, A; Kayahara, M; Kitagawa, H; Fujimura, T; Ninomiya, I; Fushida, S; Nishimura, G; Shimizu, K; Miwa, K
      Human pancreatic cancer cells disable function of Fas receptors at severallevels in Fas signal transduction pathway

      INTERNATIONAL JOURNAL OF ONCOLOGY
    33. Lee, MJ; Lee, JS; Lee, MC
      Apoptosis of skeletal muscle on steroid-induced myopathy in rats

      JOURNAL OF KOREAN MEDICAL SCIENCE
    34. Yu, SP; Canzoniero, LMT; Choi, DW
      Ion homeostasis and apoptosis

      CURRENT OPINION IN CELL BIOLOGY
    35. Schuchmann, M; Galle, PR
      Apoptosis in liver disease

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    36. Fulda, S; Meyer, E; Friesen, C; Susin, SA; Kroemer, G; Debatin, KM
      Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis

      ONCOGENE
    37. Burek, C; Roth, J; Koch, HG; Harzer, K; Los, M; Schulze-Osthoff, K
      The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells

      ONCOGENE
    38. Boldrini, L; Faviana, P; Pistolesi, F; Gisfredi, S; Di Quirico, D; Lucchi, M; Mussi, A; Angeletti, CA; Baldinotti, F; Fogli, A; Simi, P; Basolo, F; Fontanini, G
      Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in nonsmall cell lung cancer

      ONCOGENE
    39. Dunkern, TR; Fritz, G; Kaina, B
      Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation

      ONCOGENE
    40. Fulda, S; Kufer, MU; Meyer, E; van Valen, F; Dockhorn-Dworniczak, B; Debatin, KM
      Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

      ONCOGENE
    41. Glaser, T; Wagenknecht, B; Weller, M
      Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells

      ONCOGENE
    42. Rohn, TA; Wagenknecht, B; Roth, W; Naumann, U; Gulbins, E; Krammer, PH; Walczak, H; Weller, M
      CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

      ONCOGENE
    43. Trauzold, A; Wermann, H; Arlt, A; Schutze, S; Schafer, H; Oestern, S; Roder, C; Ungefroren, H; Lampe, E; Heinrich, M; Walczak, H; Kalthoff, H
      CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappa B contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

      ONCOGENE
    44. Lee, SH; Shin, MS; Kim, HS; Lee, HK; Park, WS; Kim, SY; Lee, JH; Han, SY; Park, JY; Oh, RR; Kang, CS; Kim, KM; Jang, JJ; Nam, SW; Lee, JY; Yoo, NJ
      Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma

      ONCOGENE
    45. Liu, BL; Fan, Z
      The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway

      ONCOGENE
    46. Rokhlin, OW; Guseva, N; Tagiyev, A; Knudson, CM; Cohen, MB
      Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis

      ONCOGENE
    47. Sutherland, LC; Lerman, M; Williams, GT; Miller, BA
      LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells

      ONCOGENE
    48. Suliman, A; Lam, A; Datta, R; Srivastava, RK
      Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

      ONCOGENE
    49. Santos, J; Herranz, M; Fernandez, M; Vaquero, C; Lopez, P; Fernandez-Piqueras, J
      Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in gamma-radiation-induced thymic lymphomas

      ONCOGENE
    50. Shao, RG; Cao, CX; Nieves-Neira, W; Dimanche-Boitrel, MT; Solary, E; Pommier, Y
      Activation of the Fas pathway independently of Fas ligand during apoptosisinduced by camptothecin in p53 mutant human colon carcinoma cells

      ONCOGENE
    51. Stepczynska, A; Lauber, K; Engels, IH; Janssen, O; Kabelitz, D; Wesselborg, S; Schulze-Osthoff, K
      Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation

      ONCOGENE
    52. Fukuzawa, Y; Takahashi, K; Furuta, K; Tagaya, T; Ishikawa, T; Wada, K; Omoto, Y; Koji, T; Kakumu, S
      Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)

      JOURNAL OF GASTROENTEROLOGY
    53. Shinoura, N; Sakurai, S; Asai, A; Kirino, T; Hamada, H
      Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    54. Santourlidis, S; Warskulat, U; Florl, AR; Maas, S; Pulte, T; Fischer, J; Muller, W; Schulz, WA
      Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappa B sites in prostatic carcinoma

      MOLECULAR CARCINOGENESIS
    55. Aiba-Masago, S; Masago, R; Vela-Roch, N; Talal, N; Dang, H
      Fas-mediated apoptosis in a rat acinar cell line is dependent on caspase-1activity

      CELLULAR SIGNALLING
    56. Mahiou, J; Walter, U; Lepault, F; Godeau, F; Bach, JF; Chatenoud, L
      In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice

      JOURNAL OF AUTOIMMUNITY
    57. Wosik, K; Becher, B; Ezman, A; Nalbantoglu, J; Antel, JP
      Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes

      GLIA
    58. Silvestris, F; Grinello, D; Del Prete, A; Cafforio, P; Quarto, M; Dammacco, F
      Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    59. Daniel, PT; Wieder, T; Sturm, I; Schulze-Osthoff, K
      The kiss of death: promises and failures of death receptors and ligands incancer therapy

      LEUKEMIA
    60. Wuchter, C; Krappmann, D; Cai, Z; Ruppert, V; Scheidereit, C; Dorken, B; Ludwig, WD; Karawajew, L
      In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity

      LEUKEMIA
    61. Glazyrin, AL; Adsay, VN; Vaitkevicius, VK; Sarkar, FH
      CD95-related apoptotic machinery is functional in pancreatic cancer cells

      PANCREAS
    62. Ho, CY; Wong, CK; Li, EK; Lam, CWK
      Effects of dexamethasone on the expression of Fas molecules and apoptosis of lymphocytes in patients with systemic lupus erythematosus

      IMMUNOLOGICAL INVESTIGATIONS
    63. Jaber, BL; Perianayagam, MC; Balakrishnan, VS; King, AJ; Pereira, BJG
      Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system

      JOURNAL OF LEUKOCYTE BIOLOGY
    64. Vondracek, J; Sheard, MA; Krejci, P; Minksova, K; Hofmanova, J; Kozubik, A
      Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells

      JOURNAL OF LEUKOCYTE BIOLOGY
    65. Bernassola, F; Catani, MV; Corazzari, M; Rossi, A; Melino, G
      Inactivation of multiple targets by nitric oxide in CD95-triggered apoptosis

      JOURNAL OF CELLULAR BIOCHEMISTRY
    66. Seeberger, H; Knorr, C; Muller-Hermelink, HK; Greiner, A
      Impaired CD95 (Fas, APO-1)-mediated apoptosis is a progression factor of early MALT-type lymphomagenesis

      MEDIZINISCHE KLINIK
    67. Jackle, T; Hasel, C; Melzner, I; Bruderlein, S; Jehle, PM; Moller, P
      Sustained hyposmotic stress induces cell death: apoptosis by defeat

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    68. Lebede, MJ; Ptitsina, JS; Vilkov, SA; Korablev, SB; Novikov, VV
      Membrane and soluble forms of Fas (CD95) in peripheral blood lymphocytes and in serum from burns patients

      BURNS
    69. Paquet, P; Jacob, E; Damas, P; Pierard, GE
      Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins

      BURNS
    70. Klassen, H; Schwartz, MR; Bailey, AH; Young, MJ
      Surface markers expressed by multipotent human and mouse neural progenitorcells include tetraspanins and non-protein epitopes

      NEUROSCIENCE LETTERS
    71. Gulesserian, T; Engidawork, E; Yoo, BC; Cairns, N; Lubec, G
      Alteration of caspases and other apoptosis regulatory proteins in Down syndrome

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    72. Rozenfeld-Granot, G; Toren, A; Amariglio, N; Brok-Simoni, F; Rechavi, G
      Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies

      EXPERIMENTAL HEMATOLOGY
    73. Biswas, RS; Cha, HJ; Hardwick, JM; Srivastava, RK
      Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-X-L

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    74. van Blitterswijk, WJ; van der Luit, AH; Caan, W; Verheij, M; Borst, J
      Sphingolipids related to apoptosis from the point of view of membrane structure and topology

      BIOCHEMICAL SOCIETY TRANSACTIONS
    75. Eneslatt, K; Rantapaa-Dahlqvist, S; Uddhammar, A; Sundqvist, KG
      The regulation of FasL expression - A distinguishing feature between monocytes and T lymphocytes/NK cells with possible implications for SLE

      JOURNAL OF CLINICAL IMMUNOLOGY
    76. Rodriguez-Lafrasse, C; Alphonse, G; Broquet, P; Aloy, MT; Louisot, P; Rousson, R
      Temporal relationships between ceramide production, caspase activation andmitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis

      BIOCHEMICAL JOURNAL
    77. Thompson, GJ; Langlais, C; Cain, K; Conley, EC; Cohen, GM
      Elevated extracellular [K+] inhibits death-receptor- and chemical-mediatedapoptosis prior to caspase activation and cytochrome c release

      BIOCHEMICAL JOURNAL
    78. Matarrese, P; Testa, U; Cauda, R; Vella, S; Gambardella, L; Malorni, W
      Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis

      BIOCHEMICAL JOURNAL
    79. Ma, YH; Fei, J; Hu, JH; Zhou, XG; Xia, GH; Guo, LH
      Transgenic mice ubiquitously expressing human Fas ligand develop a slight form of graft-versus-host-like disease

      ACTA PHARMACOLOGICA SINICA
    80. Fabian, Z; Torocsik, B; Kiss, K; Csatary, LK; Bodey, B; Tigyi, J; Csatary, C; Szeberenyi, J
      Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells

      ANTICANCER RESEARCH
    81. Sokolovskaya, AA; Zabotina, TN; Blokhin, DY; Inshakov, AN; Mikhailov, AD; Kadagidze, ZG; Baryshnikov, AY
      CD95-deficient cells of Jurkat/A4 subline are resistant to drug-induced apoptosis

      EXPERIMENTAL ONCOLOGY
    82. Karas, M; Zaks, TZ; Yakar, S; Dudley, ME; LeRoith, D
      TCR stimulation protects CD8(+) T cells from CD95 mediated apoptosis

      HUMAN IMMUNOLOGY
    83. Cullen, K; Davey, R; Davey, M
      The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death

      CYTOMETRY
    84. Matzke, A; Massing, U; Krug, HF
      Killing tumour cells by alkylphosphocholines: Evidence for involvement of CD95

      EUROPEAN JOURNAL OF CELL BIOLOGY
    85. Castaneda, F; Kinne, RKH
      Apoptosis induced in HepG2 cells by short exposure to millimolar concentrations of ethanol involves the Fas-receptor pathway

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    86. Koyama, S; Koike, N; Adachi, S
      Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    87. Wang, Y; Hofmann, TG; Runkel, L; Haaf, T; Schaller, H; Debatin, KM; Hug, H
      Isolation and characterization of cDNAs for the protein kinase HIPK2

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    88. Sharief, MK; Semra, YK
      Heightened expression of survivin in activated T lymphocytes from patientswith multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    89. Aktas, O; Waiczies, S; Grieger, U; Wendling, U; Zschenderlein, R; Zipp, F
      Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis

      JOURNAL OF NEUROIMMUNOLOGY
    90. Semra, YK; Seidi, OA; Sharief, MK
      Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    91. Kwon, D; Choi, C; Lee, J; Kim, KO; Kim, JD; Kim, SJ; Choi, IH
      Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis

      JOURNAL OF NEUROIMMUNOLOGY
    92. Tchorzewski, H; Glowacka, E; Banasik, M; Lewkowicz, P; Szalapska-Zawodniak, M
      Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation

      IMMUNOLOGY LETTERS
    93. Verbeke, CS; Wenthe, U; Grobholz, R; Zentgraf, H
      Fas ligand expression in Hodgkin lymphoma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    94. O'Gorman, DM; McKenna, SL; McGahon, AJ; Cotter, TG
      Inhibition of PI3-kinase sensitises HL60 human leukaemia cells to both chemotherapeutic drug- and Fas-induced apoptosis by a JNK independent pathway

      LEUKEMIA RESEARCH
    95. Roue, G; Lancry, L; Duquesne, F; Salaun, V; Troussard, X; Sola, B
      Upstream mediators of the Fas apoptotic transduction pathway are defectivein B-chronic lymphocytic leukemia

      LEUKEMIA RESEARCH
    96. Cullen, KV; Davey, RA; Davey, MW
      Drug resistance does not correlate with resistance to Fas-mediated apoptosis

      LEUKEMIA RESEARCH
    97. Annicchiarico-Petruzzelli, M; Bernassola, F; Lovat, PE; Redfern, CPF; Pearson, ADJ; Melino, G
      Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway

      MEDICAL AND PEDIATRIC ONCOLOGY
    98. Zimmermann, KC; Green, DR
      How cells die: Apoptosis pathways

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    99. Vigano, A; Pinti, M; Nasi, M; Moretti, L; Balli, F; Mussini, C; Bricalli, D; Sala, N; Bugarini, R; Vella, S; Principi, N; Cossarizza, A
      Markers of cell death-activation in lymphocytes of vertically HIV-infectedchildren naive to highly active antiretroviral therapy: The role of age

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    100. Khan, S; Koepke, A; Jarad, G; Schlessman, K; Cleveland, RP; Wang, BC; Konieczkowski, M; Schelling, JR
      Apoptosis and JNK activation are differentially regulated by Fas expression level in renal tubular epithelial cells

      KIDNEY INTERNATIONAL


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 17:13:03